Withholding and withdrawing of life support: a medicolegal dilemma.
The developments in medicine in general and the technology of life support in particular have provided the means of maintaining organ function for prolonged periods of time. However, there are many situations where life-sustaining treatment in an intensive care unit (ICU) may lead to a death with lingering and suffering of the patient, as well as burdening their family. Although often equated, withholding and/or withdrawing life-prolonging treatments that allow the patient to die needs to be differentiated from the physician-assisted suicides and euthanasia that involve the active ending of life. There is a difference between an unintended but accepted consequence of forgoing therapy and an intended result of death from suicide or euthanasia. The present-day physicians view most patient deaths as an inevitable process secondary to disorders unresponsive to treatment and/or multiple organ dysfunction syndromes. The large majority of patients dying in ICUs today succumb not after cardiopulmonary resuscitation, but rather, after the forgoing of life-sustaining treatment. Such approach has frequently caused families, institutions, and conservators of patients to resort to judicial fiat for resolution.
Sharma
B R
BR
Department of Forensic Medicine and Toxicology, Government Medical College and Hospital, Chandigarh, 160030, India. drbrsharma@yahoo.com
D003657:Decision Making; D005060:Europe; D005066:Euthanasia, Passive / Q000941:ethics* / Q000331:legislation & jurisprudence*; D006801:Humans; D007258:Informed Consent; D007362:Intensive Care Units; D008020:Life Support Care; D012297:Right to Die / Q000941:ethics / Q000331:legislation & jurisprudence; D014481:United States